Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
News

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021

  • By IPP Bureau | May 13, 2021

Eris Lifesciences Ltd has reported total income of Rs.280.41 crores during the period ended March 31, 2021 as compared to Rs.313.49 crores during the period ended December 31, 2020. It reported total income of Rs.247.5 crores during the period ended March 31, 2020. 

The company has posted net profit of Rs.68.24 crores for the period ended March 31, 2021 as against net profit of Rs.90.15 crores for the period ended December 31, 2020. It posted net profit of Rs.56.27 crores for the period ended March 31, 2020.

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021 as compared to Rs.1089.45 crores during the 12 months period ended March 31, 2020.

Eris Lifesciences has posted net profit of Rs.355.13 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.296.50 crores for the 12 months period ended March 31, 2020.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International